Statement Of Cash Flows [Abstract]

Biocartis Group NV - Filing #3122958

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
65,381,000 EUR
65,381,000 EUR
65,381,000 EUR
71,472,000 EUR
71,472,000 EUR
71,472,000 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for income tax expense
240,000 EUR
243,000 EUR
Adjustments for decrease (increase) in inventories
5,297,000 EUR
2,737,000 EUR
Adjustments for depreciation and amortisation expense
10,481,000 EUR
9,845,000 EUR
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss
1,178,000 EUR
1,362,000 EUR
Adjustments for unrealised foreign exchange losses (gains)
1,134,000 EUR
Adjustments for share-based payments
640,000 EUR
760,000 EUR
Other adjustments to reconcile profit (loss)
78,000 EUR
162,000 EUR
Cash flows from (used in) operations
38,826,000 EUR
59,285,000 EUR
Interest paid, classified as operating activities
6,027,000 EUR
6,429,000 EUR
Cash flows from (used in) operating activities
44,855,000 EUR
65,716,000 EUR
Cash flows from (used in) investing activities [abstract]
Other cash payments to acquire interests in joint ventures, classified as investing activities
1,000,000 EUR
0 EUR
Purchase of property, plant and equipment, classified as investing activities
1,569,000 EUR
3,686,000 EUR
Purchase of intangible assets, classified as investing activities
368,000 EUR
69,000 EUR
Interest received, classified as investing activities
6,000 EUR
7,000 EUR
Cash flows from (used in) investing activities
5,431,000 EUR
3,748,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
15,000,000 EUR
6,000,000 EUR
Repayments of borrowings, classified as financing activities
26,301,000 EUR
7,089,000 EUR
Interest paid, classified as financing activities
73,000 EUR
115,000 EUR
Cash flows from (used in) financing activities
22,463,000 EUR
1,204,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
27,823,000 EUR
70,668,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
426,000 EUR
522,000 EUR
Cash and cash equivalents
26,125,000 EUR
53,522,000 EUR
123,668,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.